Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Imed Infinity Medical-Limited Partnership (IMED.TA) operates in the healthcare information services sector, focusing on digital health solutions and medical data analytics. The company aims to enhance patient care through innovative technology, primarily in Israel, leveraging its proprietary software to streamline healthcare operations.
IMED generates revenue through a combination of software licensing, consulting, and data analytics services. Its competitive advantage lies in its proprietary algorithms and user-friendly interfaces that improve healthcare delivery efficiency. The company's strong relationships with healthcare providers enhance its pricing power.
Adoption rates of digital health solutions in Israel
Partnerships with healthcare providers and payers
Regulatory changes impacting healthcare technology
Technological advancements in data analytics
Technological disruption from emerging health tech startups
Regulatory changes affecting healthcare data privacy and security
Increased competition from larger healthcare IT firms
Potential market entry by tech giants like Google or Amazon
Negative cash flow impacting operational sustainability
Limited financial resources for scaling operations
moderate - The healthcare sector is generally resilient, but spending on technology can be sensitive to economic downturns.
Higher interest rates could increase financing costs for expansion and R&D, potentially impacting profitability and valuation multiples.
minimal - IMED operates with no debt, reducing its exposure to credit conditions.
growth - Investors looking for high-growth opportunities in the healthcare technology space.
high - The stock has shown significant price volatility, reflecting market sentiment and operational challenges.
